Group Financial Statements

Consolidated Statement of Cash Flows
from 1 January to 31 December 2017

In € thousand

Notes

1–12/2017

1–12/2016

Profit/(loss) for the period

 

162,788

149,618

Impairment losses, amortisation of goodwill and other intangible assets, and depreciation of property, plant and equipment

 

42,684

62,379

Impairment losses/reversal of impairment losses on other investments

 

160,387

97,956

Gain/loss on the disposal of investments

 

–57,079

–22,639

Change in deferred acquisition costs

 

1,697

10,383

Change in securities at fair value through profit or loss

 

–104,686

150,982

Change in direct insurance receivables

 

–1,868

23,412

Change in other receivables

 

–8,046

103,324

Change in direct insurance liabilities

 

5,440

–36,603

Change in other liabilities

 

61,413

25,130

Change in technical provisions

 

70,965

382,945

Change in defined benefit obligations

 

–7,513

–10,067

Change in deferred tax assets and deferred tax liabilities

 

26,800

–27,961

Change in other statement of financial position items

 

131,442

68,033

Net cash flow from operating activities

 

484,425

976,893

of which from discontinued operations

 

258,179

586,541

 

 

 

 

Proceeds from disposal of intangible assets and property, plant and equipment

 

4,566

3,504

Payments for acquisition of intangible assets and property, plant and equipment

 

–76,857

–46,926

Proceeds from disposal of consolidated companies

 

294,047

16,409

Payments for acquisition of consolidated companies

 

0

–3,293

Proceeds from disposal and maturity of other investments

 

4,703,412

4,978,861

Payments for acquisition of other investments

 

–4,999,223

–5,860,659

Change in unit-linked and index-linked life insurance investments

 

–154,564

–7,395

Net cash flow from investing activities

 

–228,620

–919,500

of which from discontinued operations

 

35,300

–593,261

 

 

 

 

Dividend payments

21

–153,024

–145,958

Transactions between owners

 

–26

–644

Payments from other financing activities

25

–1,131

–251,922

Net cash flow from financing activities

 

–154,181

–398,524

 

 

 

 

Change in cash and cash equivalents

 

101,624

–341,131

Change in cash and cash equivalents due to acquisitions or disposals of consolidated subsidiaries

 

0

770

of which from discontinued operations

 

293,479

–6,719

Change in cash and cash equivalents due to movements in exchange rates

 

–1,251

982

Cash and cash equivalents at beginning of year

13

549,934

890,083

Cash and cash equivalents at end of period

13

650,307

549,934

 

 

 

 

Income taxes paid (Net cash flow from operating activities)

 

–21,705

–49,786

Interest paid (Net cash flow from operating activities)

 

–76,966

–91,997

Interest received (Net cash flow from operating activities)

 

443,344

554,868

Dividends received (Net cash flow from operating activities)

 

27,528

77,418